Published Online:28 Jul 2017https://doi.org/10.1176/appi.ajp.2017.17010122
- Cited by
- 26 April 2024 | European Archives of Psychiatry and Clinical Neuroscience, Vol. 43
- 23 April 2024 | Medicinal Research Reviews, Vol. 9
- International Journal of Biological Macromolecules, Vol. 254
- 13 September 2023 | Journal of Medicinal Chemistry, Vol. 66, No. 18
- 22 August 2023 | Journal of Medicinal Chemistry, Vol. 66, No. 17
- European Journal of Medicinal Chemistry, Vol. 257
- 27 July 2023 | International Journal of Molecular Sciences, Vol. 24, No. 15
- Schizophrenia Research, Vol. 258
- 18 March 2023 | International Journal of Neuropsychopharmacology, Vol. 26, No. 5
- 8 May 2023 | ACS Chemical Neuroscience, Vol. 14, No. 10
- Schizophrenia Research, Vol. 255
- 25 February 2023 | Journal of Personalized Medicine, Vol. 13, No. 3
- Psychiatry Research, Vol. 321
- 8 February 2023 | International Journal of Molecular Sciences, Vol. 24, No. 4
- 14 January 2023 | World Psychiatry, Vol. 22, No. 1
- 17 June 2022 | Schizophrenia Bulletin, Vol. 48, No. 6
- 13 July 2022 | CNS Drugs, Vol. 36, No. 8
- 27 June 2022 | Expert Review of Neurotherapeutics, Vol. 22, No. 7
- Tremor and Other Hyperkinetic Movements, Vol. 12, No. 1
- 25 February 2022 | Schizophrenia Bulletin, Vol. 48, No. 3
- 7 April 2022 | Schizophrenia Bulletin Open, Vol. 3, No. 1
- Neuroscience & Biobehavioral Reviews, Vol. 132
- 26 February 2021 | npj Schizophrenia, Vol. 7, No. 1
- 5 July 2021 | Neuroscience Bulletin, Vol. 37, No. 11
- 15 October 2021 | CNS Drugs, Vol. 35, No. 11
- 1 January 2021 | RSC Medicinal Chemistry, Vol. 12, No. 9
- 16 June 2021 | Expert Opinion on Pharmacotherapy, Vol. 22, No. 14
- 2 June 2021 | Journal of Medicinal Chemistry, Vol. 64, No. 12
- 25 January 2021 | Experimental and Therapeutic Medicine, Vol. 21, No. 3
- Targeting Serotonin 5-HT2A Receptors to Better Treat Schizophrenia: Rationale and Current Approaches11 August 2020 | CNS Drugs, Vol. 34, No. 9
- 21 July 2020 | Expert Opinion on Drug Safety, Vol. 19, No. 8
- 28 January 2020 | Schizophrenia Bulletin, Vol. 46, No. 4
- 8 June 2020 | Expert Opinion on Emerging Drugs, Vol. 25, No. 2
- JAMA Psychiatry, Vol. 77, No. 4
- European Neuropsychopharmacology, Vol. 33
- 1 April 2022 | Dialogues in Clinical Neuroscience, Vol. 22, No. 1
- 15 February 2020 | Schizophrenia Bulletin Open, Vol. 1, No. 1
- 1 February 2020 | Neuropsychiatric Disease and Treatment, Vol. Volume 16
- 4 September 2019 | CNS Spectrums, Vol. 24, No. S1
- 8 November 2018 | Expert Opinion on Pharmacotherapy, Vol. 20, No. 1
- 1 April 2022 | Dialogues in Clinical Neuroscience, Vol. 20, No. 3
- Schizophrenia Research, Vol. 197